Consumers Union in the US has been awarded a $4.4 million grant to support a public education program designed to eliminate huge gaps in public knowledge about prescription drugs.
The grant will help expand the availability of free unbiased prescription drug information to counter the $10 billion spent on advertising in the US by drug companies each year.
The grant money is available as part of a $38 million dollar consumer protection settlement between the Attorneys General of 50 states and Warner-Lambert, now owned by Pfizer. In 2004, Warner-Lambert agreed to pay $430 million to resolve allegations that it illegally marketed its drug, Neurontin®, for "off-label" purposes not approved by the Food and Drug Administration.
No comments:
Post a Comment